| . | Healthy volunteers . | Stable CAD patients . |
|---|---|---|
| Mean age (range) | 25.6 years (18–54) | 62.2 years (46–75) |
| Gender | 10 male, 14 female | 23 male 1 female |
| Race | 23 Caucasian, 1 Black | 22 Caucasian, 1 Asian, 1 mixed |
| Mean weight (range) | 70.1 kg (54–92) | 84.7 kg (62–105) |
| Mean height (range) | 176 cm (164–197) | 177 cm (164–193) |
| Mean BMI (range) | 22.5 (19–25) | 27 (21–32) |
| ApoA-1 (mg/dL) (SD) | 157.3 (35.3) | 121.5 (23.1) |
| Total cholesterol (mmol/L) (SD) | 4.56 (0.77) | 4.28 (0.80) |
| HDL-C (mmol/L) (SD) | 1.43 (0.33) | 1.21 (0.35) |
| LDL-C (mmol/L) (SD) | 2.18 (0.44) | 2.22 (0.54) |
| Phospholipid (mmol/L) (SD) | 2.55 (0.47) | 2.38 (0.26) |
| Pre-beta 1 HDL (mmol/L) (SD) | 40.8 (14.6) | 65.5 (24.9) |
| Triglyceride (mmol/L) (SD) | 0.95 (0.28) | 1.46 (0.61) |
| Endogenous ApoA-1 (mg/dL) (SD) | 157.2 (35.3) | 121.4 (23.1) |
| ApoA-II (mg/dL) (SD) | 30.2 (4.9) | 27.9 (4.12) |
| Apo-B (mg/dL) (SD) | 77.5 (15.9) | 78.4 (20.6) |
| Apo-E (mg/dL) (SD) | 1.93 (0.55) | 1.90 (0.42) |
| ABCA1% (efflux/4 h) (SD) | 6.23 (2.03) | 6.29 (2.52) |
| ABCG1% (efflux/4 h) (SD) | 6.24 (1.07) | 6.97 (0.96) |
| SRB1% (efflux/4 h) (SD) | 5.82 (1.17) | 4.71 (0.77) |
| . | Healthy volunteers . | Stable CAD patients . |
|---|---|---|
| Mean age (range) | 25.6 years (18–54) | 62.2 years (46–75) |
| Gender | 10 male, 14 female | 23 male 1 female |
| Race | 23 Caucasian, 1 Black | 22 Caucasian, 1 Asian, 1 mixed |
| Mean weight (range) | 70.1 kg (54–92) | 84.7 kg (62–105) |
| Mean height (range) | 176 cm (164–197) | 177 cm (164–193) |
| Mean BMI (range) | 22.5 (19–25) | 27 (21–32) |
| ApoA-1 (mg/dL) (SD) | 157.3 (35.3) | 121.5 (23.1) |
| Total cholesterol (mmol/L) (SD) | 4.56 (0.77) | 4.28 (0.80) |
| HDL-C (mmol/L) (SD) | 1.43 (0.33) | 1.21 (0.35) |
| LDL-C (mmol/L) (SD) | 2.18 (0.44) | 2.22 (0.54) |
| Phospholipid (mmol/L) (SD) | 2.55 (0.47) | 2.38 (0.26) |
| Pre-beta 1 HDL (mmol/L) (SD) | 40.8 (14.6) | 65.5 (24.9) |
| Triglyceride (mmol/L) (SD) | 0.95 (0.28) | 1.46 (0.61) |
| Endogenous ApoA-1 (mg/dL) (SD) | 157.2 (35.3) | 121.4 (23.1) |
| ApoA-II (mg/dL) (SD) | 30.2 (4.9) | 27.9 (4.12) |
| Apo-B (mg/dL) (SD) | 77.5 (15.9) | 78.4 (20.6) |
| Apo-E (mg/dL) (SD) | 1.93 (0.55) | 1.90 (0.42) |
| ABCA1% (efflux/4 h) (SD) | 6.23 (2.03) | 6.29 (2.52) |
| ABCG1% (efflux/4 h) (SD) | 6.24 (1.07) | 6.97 (0.96) |
| SRB1% (efflux/4 h) (SD) | 5.82 (1.17) | 4.71 (0.77) |
| . | Healthy volunteers . | Stable CAD patients . |
|---|---|---|
| Mean age (range) | 25.6 years (18–54) | 62.2 years (46–75) |
| Gender | 10 male, 14 female | 23 male 1 female |
| Race | 23 Caucasian, 1 Black | 22 Caucasian, 1 Asian, 1 mixed |
| Mean weight (range) | 70.1 kg (54–92) | 84.7 kg (62–105) |
| Mean height (range) | 176 cm (164–197) | 177 cm (164–193) |
| Mean BMI (range) | 22.5 (19–25) | 27 (21–32) |
| ApoA-1 (mg/dL) (SD) | 157.3 (35.3) | 121.5 (23.1) |
| Total cholesterol (mmol/L) (SD) | 4.56 (0.77) | 4.28 (0.80) |
| HDL-C (mmol/L) (SD) | 1.43 (0.33) | 1.21 (0.35) |
| LDL-C (mmol/L) (SD) | 2.18 (0.44) | 2.22 (0.54) |
| Phospholipid (mmol/L) (SD) | 2.55 (0.47) | 2.38 (0.26) |
| Pre-beta 1 HDL (mmol/L) (SD) | 40.8 (14.6) | 65.5 (24.9) |
| Triglyceride (mmol/L) (SD) | 0.95 (0.28) | 1.46 (0.61) |
| Endogenous ApoA-1 (mg/dL) (SD) | 157.2 (35.3) | 121.4 (23.1) |
| ApoA-II (mg/dL) (SD) | 30.2 (4.9) | 27.9 (4.12) |
| Apo-B (mg/dL) (SD) | 77.5 (15.9) | 78.4 (20.6) |
| Apo-E (mg/dL) (SD) | 1.93 (0.55) | 1.90 (0.42) |
| ABCA1% (efflux/4 h) (SD) | 6.23 (2.03) | 6.29 (2.52) |
| ABCG1% (efflux/4 h) (SD) | 6.24 (1.07) | 6.97 (0.96) |
| SRB1% (efflux/4 h) (SD) | 5.82 (1.17) | 4.71 (0.77) |
| . | Healthy volunteers . | Stable CAD patients . |
|---|---|---|
| Mean age (range) | 25.6 years (18–54) | 62.2 years (46–75) |
| Gender | 10 male, 14 female | 23 male 1 female |
| Race | 23 Caucasian, 1 Black | 22 Caucasian, 1 Asian, 1 mixed |
| Mean weight (range) | 70.1 kg (54–92) | 84.7 kg (62–105) |
| Mean height (range) | 176 cm (164–197) | 177 cm (164–193) |
| Mean BMI (range) | 22.5 (19–25) | 27 (21–32) |
| ApoA-1 (mg/dL) (SD) | 157.3 (35.3) | 121.5 (23.1) |
| Total cholesterol (mmol/L) (SD) | 4.56 (0.77) | 4.28 (0.80) |
| HDL-C (mmol/L) (SD) | 1.43 (0.33) | 1.21 (0.35) |
| LDL-C (mmol/L) (SD) | 2.18 (0.44) | 2.22 (0.54) |
| Phospholipid (mmol/L) (SD) | 2.55 (0.47) | 2.38 (0.26) |
| Pre-beta 1 HDL (mmol/L) (SD) | 40.8 (14.6) | 65.5 (24.9) |
| Triglyceride (mmol/L) (SD) | 0.95 (0.28) | 1.46 (0.61) |
| Endogenous ApoA-1 (mg/dL) (SD) | 157.2 (35.3) | 121.4 (23.1) |
| ApoA-II (mg/dL) (SD) | 30.2 (4.9) | 27.9 (4.12) |
| Apo-B (mg/dL) (SD) | 77.5 (15.9) | 78.4 (20.6) |
| Apo-E (mg/dL) (SD) | 1.93 (0.55) | 1.90 (0.42) |
| ABCA1% (efflux/4 h) (SD) | 6.23 (2.03) | 6.29 (2.52) |
| ABCG1% (efflux/4 h) (SD) | 6.24 (1.07) | 6.97 (0.96) |
| SRB1% (efflux/4 h) (SD) | 5.82 (1.17) | 4.71 (0.77) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
